Hosted on MSN1mon
Health Canada approves GSK’s Ojjaara for myelofibrosis in anaemia patients
Health Canada has granted approval for GlaxoSmithKline’s (GSK) Ojjaara (momelotinib) for treating myelofibrosis (MF) in adults with moderate-to-severe anaemia. The once-daily, oral treatment is ...
pharmaphorum4d
GSK, Sanofi and Haleon 'facing billions of dollars in Zantac liability'
It also revealed that outside the US there are several class actions and in excess of 100 personal injury cases pending against GSK in Canada, along with a class action in Israel. In this video ...